Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 3NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 61Thoracic 57Breast 53Gastrointestinal 17Other solid neoplasm 14Genitourinary 14Head & Neck 13Tumor-Agnostic 9Dermatologic 6Sarcoma 5Lymphoid 5Other hematologic neoplasm 4Endocrine 2Other neoplasm 1CNS 1

Conditions

Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

Sulindac 4Biopsy 4Carboplatin 3Vaginal Smears 2Specimen Handling 2Cyclophosphamide 2Colposcopy 2Aspirin 2tipifarnib 1tanespimycin 1sargramostim 1radium Ra 223 dichloride 1pirfenidone 1fludarabine phosphate 1alethine 1X-Rays 1Taxes 1Sorafenib 1Resistance Training 1Radiotherapy 1Polymerase Chain Reaction 1Photons 1Peripheral Blood Stem Cell Transplantation 1Papanicolaou Test 1Paclitaxel 1Mycophenolic Acid 1Microarray Analysis 1Magnetic Resonance Spectroscopy 1Lovastatin 1Interleukin-12 Subunit p35 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Paclitaxel × Other neoplasm × Clear all
NCT04090398 2026-05-13

Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones

National Cancer Institute (NCI)

Phase 2 Active not recruiting
70 enrolled
BreastOther neoplasm

Anatomic Stage IV Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡